Inspire Medical Systems Inc INSP

Morningstar Rating
$53.27 +2.67 (5.28%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INSP is trading within a range we consider fairly valued.
Price
$50.60
Fair Value
LOCK|.&t>w>@
Uncertainty
LOCK|%? ^L@<
1-Star Price
LOCK|q.^xhMhy
5-Star Price
LOCK|.r@s?^q
Economic Moat
LOCK|QvW
Capital Allocation

News

Trading Information

Previous Close Price
$50.60
Day Range
$50.5353.40
52-Week Range
$38.91147.03
Bid/Ask
$48.78 / $53.60
Shares Outstanding
28.81M
Market Cap
$1.53B
Volume/Avg
2,672 / 1M

Key Statistics

Price/Earnings (Normalized)
19.62
Price/Sales
1.62
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
6.86%

Company Profile

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
1,333

Valuation

Metric
INSP
Price/Earnings (Normalized)
20.65
Price/Book Value
1.94
Price/Sales
1.71
Price/Cash Flow
8.08
Price/Earnings
INSP

Financial Strength

Metric
INSP
Quick Ratio
4.35
Current Ratio
6.34
Interest Coverage
Quick Ratio
INSP

Profitability

Metric
INSP
Return on Assets (Normalized)
9.08%
Return on Equity (Normalized)
10.63%
Return on Invested Capital (Normalized)
8.46%
Return on Assets
INSP

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|y#?hPQLOCK|#lJWS$177B
Stryker Corp
SYK
LOCK|?$r^$#!mLOCK|$D$122B
Medtronic PLC
MDT
LOCK|<QbS@$LOCK|@^JJ$107B
Boston Scientific Corp
BSX
LOCK|M>$V?dLOCK|>CzD<$65B
Edwards Lifesciences Corp
EW
LOCK|flD&%PflLOCK|L#^K$49B
DexCom Inc
DXCM
LOCK|Q&KBT!TLOCK|!@Yn#$29B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|h<#D<!LOCK|Fg$29B
Koninklijke Philips NV ADR
PHG
LOCK|SBYLOCK|p!$26B
Steris PLC
STE
LOCK|Y#r@k?>LOCK|$F%>f$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|NSpb!%BLOCK|RQw$17B

Sponsor Center